Upgrade to SI Premium - Free Trial

BlackRock (BLK) Isn't Immune To Market Volatility - Goldman Sachs

April 13, 2018 6:26 AM
Goldman Sachs analyst, Alexander Blostein, reiterated his Buy rating on shares of BlackRock (NYSE: BLK) after the company reported a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst EPS Change Analyst EPS View Analyst PT Change

Next Articles